LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0962 | Name | NBR2 | Aliases | NCRNA00192 | |
Species | Homo sapiens | Chromosome | 17 | Start site | 43125610 | |
End site | 43153671 | Chain | plus | Exon NO. | 5 | |
Assembly | Ensembl Release 89 | Class | processed transcript | NCBI accession | NR_003108 | |
Ensembl | ENSG00000198496 | Sequence |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source | ||
cancer | N/A | N/A | down-regulated | interaction | involving checked cell cycling, altered apoptosis/autophagy response, and tumor development in vivo | 26999735 | |||
Interaction | |||||||||
---|---|---|---|---|---|---|---|---|---|
Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||||
AMP-activated protein kinase (AMPK) | RNA-Protein | regulation | NBR2 in turn interacts with AMPK and promotes AMPK kinase activity | 26999735 | |||||